| Page 231 | Kisaco Research

Quincy Byrdsong

Vice President of Research Operations

Ballad Health

Centering Health Equity in Clinical Trial Design

How are we ensuring under-served patient populations voices are considered in trial format?
Optimizing both population data and clinical data analytics to develop accessible and equitable clinical trials.

health equity

clinical trials

Author:

Brittany Gerald

Associate Director, Clinical Trial Diversity and Inclusion, Patient and Site Experience (PASE)

Moderna

Author:

Benjamin Young

Senior Global Medical Director

ViiV Healthcare

Author:

Sandra Amaro

Head of Clinical Trial Diversity

Pfizer

Read more about Centering Health Equity in Clinical Trial Design

Data Driven Solutions and Successes for Clinical Trial Diversity

Discussing implementation of RWE in upstream and downstream clinical operations to improve diversity strategy.
Platforming cases of qualitative data retrieval and how this aids understanding of under-served populations.

health equity

Data

clinical trials

Author:

Mary Nwokedi

Director, Clinical Trial Diversity: Science and Regulatory Advocacy

PhRMA

Author:

Kemi Willaims

Senior Director, Patient Science

AstraZeneca

Read more about Data Driven Solutions and Successes for Clinical Trial Diversity

From Competitors to Collaborators: Co-operative Pharmaceutical Developments & Health Equity Solutions

Platforming the tangible successes pharmaceutical companies are having to improve DEI in clinical trials.
Highlighting data-driven strategies to improve site capabilities for underserved-patient engagement, recruitment, and experience.
The importance of collaboration and standardization from a large-scale initative perspective, where are we at and where do we need to be.

Author:

Michel Reid

Global Head of Demographics & Diversity

GSK

Author:

Alana Miller

Associate Director, Diversity in Clinical Trials

Merck

Author:

Monique Adams

Executive Director, Diversity & Inclusion in Clinical Trials

Sanofi

Read more about From Competitors to Collaborators: Co-operative Pharmaceutical Developments & Health Equity Solutions

Patient Perspectives: Progressing Health Equity and Empowering Underserved Communities

Patients are the quality control of health equity developments, sharing experiences of clinical trial participation, highlighting the successes of improved patient experience.
What can the industry learn from patient experts, discussing the implementation of patient voice into health equity strategic programs.
Includes an open Q&A towards the end of the panel to ask critical questions to patients and facilitate industry learning.

health equity